Development
DexCom, Inc.
DXCM
$82.26
$1.642.03%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 179.19% | 19.27% | 127.70% | -50.05% | 1,832.08% |
| Total Depreciation and Amortization | 30.93% | 22.96% | 0.23% | 13.04% | 64.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.96% | -535.42% | -160.75% | -60.17% | -59.09% |
| Change in Net Operating Assets | -291.06% | 17.77% | -9.65% | 152.82% | -24.53% |
| Cash from Operations | 0.83% | -8.19% | 10.13% | 118.87% | 25.24% |
| Capital Expenditure | 17.32% | 53.42% | 35.52% | 26.48% | 20.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 457.89% | -138.17% | -830.52% | 63.52% | 68.70% |
| Cash from Investing | 313.76% | -178.28% | -283.64% | 54.66% | 60.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 15.32% | -- | 21.78% | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 590.00% | 83.33% | -2,281.40% | 77.08% | -25.00% |
| Cash from Financing | -63,090.00% | -15.37% | 21,948.84% | 111.32% | -25.00% |
| Foreign Exchange rate Adjustments | -10.29% | 52.05% | 48.84% | 210.00% | 1,460.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.53% | -1,377.75% | 2,862.18% | 94.35% | 85.75% |